Rapid tumor necrosis induced by electrochemotherapy with intratumoral injection of bleomycin in a hamster tongue cancer model

International Journal of Oral and Maxillofacial Surgery

Volumn 29, Issue 2, 2000, Pages 119-125

  Omura, Susumu ^a   Tsuyuki, Yoshiharu ^a   Ohta, Shinsuke ^a   Li, Xianqi ^a   Bukawa, Hiroki ^a   Fujita, Kiyohide ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Bleomycin; Electrochemotherapy; Electroporation; Tongue cancer

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; BLEOMYCIN;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG DELIVERY SYSTEM; ELECTROPORATION; EXPERIMENTAL NEOPLASM; HAMSTER; INTRALESIONAL DRUG ADMINISTRATION; MALE; NECROSIS; NONPARAMETRIC TEST; PATHOLOGY; SYRIAN HAMSTER; TONGUE TUMOR;

ANALYSIS OF VARIANCE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BLEOMYCIN; CRICETINAE; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; ELECTROPORATION; INJECTIONS, INTRALESIONAL; MALE; MESOCRICETUS; NECROSIS; NEOPLASMS, EXPERIMENTAL; STATISTICS, NONPARAMETRIC; TONGUE NEOPLASMS;

EID: 0034164167     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0901-5027(00)80008-9     Document Type: Article

References (27)

1. BELEHRADEK M, DOMENGE C, LUBOINSKI B, ORLOWSKI S, BELEHRADEK J JR, MIR LM. Electrochemotherapy a new antitumor treatment. First clinical phase I-II trial. Cancer 1993: 72: 3694-700.
2. BELEHRADEK J JR, ORLOWSKI S, PODDEVIN B, PAOLETTI C, MIR LM. Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 1991: 27: 73-6.
3. CEMAZAR M, et al. Improved therapeutic effect of electrochemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization on EAT tumor model in mice. Radiol Oncol 1995: 29: 121-7.
4. DEV SB, HOFMANN GA. Electrochemotherapy - a novel method of cancer treatment. Cancer Treat Rev 1994: 20: 105-15.
5. FUJITA K, KAKU T, SASAKI M, ONOE T. Experimental production of lingual carcinoma in hamsters by local application of 9,10-dimethyl-1,2-benzanthracene. J Dent Res 1973: 52: 327-32.
6. GIAVAZZI R, CAMPBELL DE, JESSUP JM, CLEARY K, FIDLER IJ. Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res 1986: 46: 1928-33.
7. GILBERT RA, JAROZESKI MJ, HELLER R. Novel electrode designs for electrochemotherapy. Biochim Biophys Acta 1997: 1334: 9-14.
8. GLASS LF, PEPINE ML, FENSKE NA, JAROZESKI MJ, REINTGEN DS, HELLER R. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 1996: 132: 1353-7.
9. HASEGAWA H, et al. An electrochemotherapy model for rat tongue carcinoma. J Oral Pathol Med 1998: 27: 249-54.
10. HELLER R, JAROZESKI MJ, PERROTT R, MESSINA J, GILBERT R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res 1997: 7: 10-8.
11. HELLER R, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996: 77: 964-71.
12. HUGHES RS, FRENKEL EP. The role of chemotherapy in head and neck cancer. Am J Clin Oncol 1997: 20: 449-61.
13. JAROZESKI MJ, GILBERT R, HELLER R. Electrochemotherapy: an emerging drug delivery method for the treatment of cancer. Adv Drug Deliv Rev 1997: 26: 185-97.
14. JAROZESKI MJ, GILBERT R, PERROTT R, HELLER R. Enhanced effects of multiple treatment electrochemotherapy. Melanoma Res 1996: 6: 427-33.
15. JAROZESKI MJ, GILBERT RA, HELLER R. In vivo antitumor effects of electrochemotherapy in a hepatoma model. Biochim Biophys Acta 1997: 1334: 15-8.
16. MIR LM, BANOUN H, PAOLETTI C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 1988: 175: 15-25.
17. MIR LM, ORLOWSKI S, BELEHRADEK J JR, PAOLETTI C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991: 27: 68-72.
18. NEUMAN E, SCHAEFER-RIDDER M, WANG Y, HOJSCHNEIDER PH. Gene transfer into mouse lyoma cells by electroporation in high electric field. EMBO J 1982: 1: 841-5.
19. OMURA S, TSUYUKI Y, OHTA S, BUKAWA H, FUJITA K. In vivo antitumor effects of electrochemotherapy in a tongue cancer model. J Oral Maxillofac Surg 1999: 57: 965-72.
20. ORLOWSKI S, BELEHRADEK J JR, PAOLETTI C, MIR LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988: 37: 4727-33.
21. PODDEVIN B, ORLOWSKI S, BELEHRADEK J JR, MIR LM. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 1991: 42 (Suppl): S67-75.
22. 2 with HeLa cells. Cancer Res 1984: 44: 1541-6.
23. SALFORD LG, PERSSON BRR, BRUN A, CEBERG CP, KONGSTAD PC, MIR LM. A new brain tumor therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun 1993: 194: 938-43.
24. SERSA G, KONTIC V, CEMAZAR M, MIKLAVCIC D, KOTNIC A. Electrochemotherapy with bleomycin in SA-1 tumor-bearing mice: natural resistance and immune responsiveness. Anticancer Drugs 1996: 7: 785-91.
25. SERSA G, CEMAZAR M, MENART V, GABERC-POREKAR V, MIKLAVCIC D. Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-α on SA-1 tumors in mice. Cancer Lett 1997: 116: 85-92.
26. TADA T, MATSUMOTO K, SUZUKI H. Electrochemotherapy significantly inhibits the growth of colon 26 tumors in mice. Surg Today 1997: 27: 506-10.
27. YABUSHITA H, et al. Effects of electrochemotherapy on CaSki cells derived from a cervical squamous cell carcinoma. Gynecol Oncol 1997: 65: 297-303.